Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A W Kinkel

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Current Therapeutic Research, Clinical and Experimental|January 1, 1977
Bioavailability of two brands of quinidine gluconate administered on a multiple-dose regimenT C Smith, A W Kinkel
Journal of Chromatography|June 8, 1984
Gas chromatographic determination of bevantolol in plasmaE J Randinitis, C Nelson, A W Kinkel
International Journal of Clinical Pharmacology, Therapy and Toxicology|April 1, 1973
The absorption and excretion of ethosuximideR A Buchanan, A W Kinkel, T C Smith
Epilepsia|July 1, 1990
Pharmacokinetic profile of a 300-mg extended phenytoin sodium capsule (Dilantin) formulationE J Randinitis, R A Buchanan, A W Kinkel
Journal of Chromatography|December 19, 1986
Liquid chromatographic determination of gemfibrozil and its metabolite in plasmaE J Randinitis, T D Parker, A W Kinkel
Clinical Pharmacology and Therapeutics|August 1, 1976
Metabolism of ethosuximideJ R Goulet, A W Kinkel, T C Smith
Journal of Chromatography|April 13, 1984
Gas chromatographic determination of gemfibrozil and its metabolites in plasma and urineE J Randinitis, A W Kinkel, C Nelson, et al.
Clinical Chemistry|June 1, 1976
Simplified fluorometric assay for diphenylhydantoin in plasmaW A Dill, A Leung, A W Kinkel, et al.
Clinical Pharmacology and Therapeutics|June 1, 1976
Absorption of pyrvinium pamoateT C Smith, A W Kinkel, C M Gryczko, et al.
Journal of Clinical Pharmacology|January 1, 1989
Effect of a high-fat meal on the bioavailability of a polymer-coated erythromycin particle tablet formulationE J Randinitis, A J Sedman, P G Welling, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Current Therapeutic Research, Clinical and Experimental|January 1, 1977
Bioavailability of two brands of quinidine gluconate administered on a multiple-dose regimenT C Smith, A W Kinkel
Journal of Chromatography|June 8, 1984
Gas chromatographic determination of bevantolol in plasmaE J Randinitis, C Nelson, A W Kinkel
International Journal of Clinical Pharmacology, Therapy and Toxicology|April 1, 1973
The absorption and excretion of ethosuximideR A Buchanan, A W Kinkel, T C Smith
Epilepsia|July 1, 1990
Pharmacokinetic profile of a 300-mg extended phenytoin sodium capsule (Dilantin) formulationE J Randinitis, R A Buchanan, A W Kinkel
Journal of Chromatography|December 19, 1986
Liquid chromatographic determination of gemfibrozil and its metabolite in plasmaE J Randinitis, T D Parker, A W Kinkel
Clinical Pharmacology and Therapeutics|August 1, 1976
Metabolism of ethosuximideJ R Goulet, A W Kinkel, T C Smith
Journal of Chromatography|April 13, 1984
Gas chromatographic determination of gemfibrozil and its metabolites in plasma and urineE J Randinitis, A W Kinkel, C Nelson, et al.
Clinical Chemistry|June 1, 1976
Simplified fluorometric assay for diphenylhydantoin in plasmaW A Dill, A Leung, A W Kinkel, et al.
Clinical Pharmacology and Therapeutics|June 1, 1976
Absorption of pyrvinium pamoateT C Smith, A W Kinkel, C M Gryczko, et al.
Journal of Clinical Pharmacology|January 1, 1989
Effect of a high-fat meal on the bioavailability of a polymer-coated erythromycin particle tablet formulationE J Randinitis, A J Sedman, P G Welling, et al.
Pageof 3